Skip to main content
GMRS logo

GMRS · GMR Solutions Inc.

Track GMRS — free
$13.08 +0.29 (+2.27%)
Market Cap
$685.54M
Shares
54.02M

GMRS metrics

34 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.79
Market cap
$685.54M

Price action

19 metrics
Price change (1W)
+2.1%
Price change (30D)
-0.2%
Price change (3M)
+22.2%
Price change (6M)
Price change (YTD)
Price change (1Y)
Trailing year
Price change (5Y)
52-week high
52-week low
Change from 52-week high
Change from 52-week low
Annualized volatility
68.5%
Beta
RSI (14D)
48.8
Price vs SMA 50
-4.0%
Price vs SMA 200
Avg volume (3M)
738,667
Relative volume
1.1
Average dollar volume
$9.89M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
54.02M

Valuation

12 metrics
P / E (TTM)
Trailing earnings
PEG ratio
EV / revenue
EV / EBITDA
EV / EBIT
P / sales
P / book
0.9
reciprocal yield 115.1%
FCF yield
TTM · current market cap
Buyback yield
P / FCF
P / operating cash flow
Earnings yield

Historical valuation

8 metrics
P / E historical average (3Y)
P / E historical average (5Y)
EV / revenue historical average (3Y)
EV / revenue historical average (5Y)
EV / EBIT historical average (3Y)
EV / EBIT historical average (5Y)
EV / EBITDA historical average (3Y)
EV / EBITDA historical average (5Y)

Dividends & buybacks

7 metrics
Dividend yield
Trailing 12 months
Payout ratio
Shareholder yield
Dividend / share (TTM)
Dividend growth YoY
Dividend growth streak
Last ex-dividend

Earnings calendar

2 metrics
Next earnings
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
Operating margin
Trailing 12 months
Net margin
Gross profit (TTM)
Operating profit (TTM)
Net income (TTM)
Trailing 12 months
Diluted EPS (TTM)
FCF margin
Effective tax rate

Per share

11 metrics
Revenue per diluted share (TTM)
Gross profit per diluted share (TTM)
Operating profit per diluted share (TTM)
EBITDA per diluted share (TTM)
Net income per diluted share (TTM)
Operating cash flow per diluted share (TTM)
Free cash flow per diluted share (TTM)
Capital expenditures per diluted share (TTM)
R&D per diluted share (TTM)
Stock compensation per diluted share (TTM)
Book value per share
$9.62

Growth

11 metrics
Revenue growth YoY
+3.3%
Year over year
Net income growth YoY
-135.0%
Revenue (TTM)
Trailing 12 months
EPS growth YoY
-781.5%
Shares change YoY
-57.7%
Year over year · fewer shares
Revenue CAGR (3Y)
Revenue CAGR (5Y)
EPS CAGR (3Y)
EPS CAGR (5Y)
FCF CAGR (3Y)
FCF CAGR (5Y)

Quality

14 metrics
Return on equity
Return on assets
Debt / equity
5.6
Current ratio
2.0
EBITDA (TTM)
Free cash flow (TTM)
Quick ratio
1.9
Interest coverage
Net debt / EBITDA
Return on invested capital
Trailing 12 months
Net cash
−$3.93B
Latest balance sheet
Cash & equivalents
$420.00M
Total assets
$7.43B
Total debt
$4.42B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
Capital expenditures (TTM)
R&D (TTM)
SG&A (TTM)
Stock compensation (TTM)
R&D / revenue
Stock compensation / revenue

Ownership (13F)

3 metrics
13F filers
61
13F filer change QoQ
+61
Institutional ownership
94.6%

Short interest

3 metrics
Short interest
4.5%
Latest settlement · 2.6 days to cover
Days to cover
2.6d
Short-squeeze score
68 / 100

Insider activity

2 metrics
Net insider buying (90D)
Insider-sentiment score

Risk flags

1 metrics
Going concern
Key facts CIK 1898718 CUSIP 38013D106 13F (30d) 64 filings 61 filers Visit website Investor relations